spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Stanford University Medical Center 

 HSMN NewsFeed - 28 Feb 2024
Baird Medical Expands Presence in the United States
Devices Oncology Personnel
 HSMN NewsFeed - 11 Sep 2020
Targazyme Appoints Jim Caggiano as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2019
Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360(TM) System At AANS 2019
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 29 Jan 2019
Nanospectra Biosciences Names Michael Brawer, M.D. as Chief Medical Officer
Devices Oncology Urology Personnel
 HSMN NewsFeed - 9 Nov 2018
Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2018
Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 25 Aug 2016
Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor
Devices Neurology
 HSMN NewsFeed - 19 Apr 2016
Rodney D. Altman, MD Joins Valeritas Board of Directors
Devices Drug Delivery Endocrinology Personnel
 HSMN NewsFeed - 22 May 2013
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2012
Aequus BioPharma Appoints Ronald J. Berenson, M.D. President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2012
Cook Medical’s Zilver(R) PTX(R) Trial Shows Sustained Patency after Three Years
Devices Interventional
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 24 Aug 2011
Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market
Devices Monitoring
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2010
In the Fast Lane: Shorter Treatment Times for Cancer Patients with Increased Speed, Power and Precision of Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 6 Jul 2010
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 11 Jun 2010
Cook Medical Files Pre-Market Approval Application for FDA Approval of Zilver(R) PTX(R) Drug-Eluting Stent Platform
Devices Interventional
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jan 2010
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Sep 2009
Hansen Medical Unveils Next Generation Robotic Catheter System and Two New Catheters Offering Advanced Navigation Within the Heart
Devices Cardiology FDA
 HSMN NewsFeed - 11 Aug 2009
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
Devices Interventional
 HSMN NewsFeed - 11 Aug 2009
Zilver PTX Stent from Cook Medical Gains CE Mark
Devices Interventional Regulatory
 HSMN NewsFeed - 14 May 2009
Gore Announces First Implant of 31 mm GORE EXCLUDER AAA Endoprosthesis in the United States
Devices Interventional
 HSMN NewsFeed - 7 May 2009
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
Devices Interventional
 HSMN NewsFeed - 2 Mar 2009
Hansen Medical Announces Strategic Relationship With Advanced Cardiac Therapeutics and Procurement of Certain Exclusive Rights to Its Patented Microwave Radiometry Technology
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2008
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2008
Montecito Medical Ventures Announces Alliance With Accuray, a Leading Developer of Cancer Treatment Technology
Devices Oncology
 HSMN NewsFeed - 29 May 2008
StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease
Regenerative Medicine Nurology
 HSMN NewsFeed - 19 May 2008
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2008
CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
Devices Oncology
 HSMN NewsFeed - 7 Jan 2008
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Dec 2007
Breast Cancer Gene Mutation More Common in Hispanic, Young Black Women, Stanford/NCCC Study Finds
Oncology
 HSMN NewsFeed - 30 Nov 2007
Cardima Appoints Dr. Sung Chun as Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 26 Oct 2007
Boston Scientific Announces Additions to Clinical Sciences Organization
Devices Personnel
 HSMN NewsFeed - 14 Jun 2007
Philips Ships Landmark 3,000th Brilliance CT System and Showcases Continued Innovations to Flagship Line of Scanners and Solutions
Devices Radiology
 HSMN NewsFeed - 9 May 2007
Siemens Medical Solutions Revolutionizes Electrophysiology With syngo(R) DynaCT Cardiac
Devices Cardiology
 HSMN NewsFeed - 2 Apr 2007
Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2007
AngioScore Receives Premarket Approval (PMA) for AngioSculpt(R) Scoring Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Nov 2006
Bone Solutions Inc. appoints Stephen A. Schendel, MD, DDS, Professor of Plastic and Reconstructive Surgery at Stanford University Medical Center, as its Chief Medical Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 12 Nov 2006
ENBREL is the First Biologic to Publish Data Showing Safety and Sustained Efficacy for up to Nine Years in Patients with Moderate-to-Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 3 Nov 2006
PTC Therapeutics Announces Positive Phase 2 Results For PTC124 in Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2006
MRI Analysis Could Prevent Brain Damage From Stroke, Stanford Study Finds
Devices Radiology Neurology
 HSMN NewsFeed - 1 Jun 2006
Lipid Sciences, Inc. Initiates Human Clinical Trial of Plasma Delipidation System
Devices Cardiology
 HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 57

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 57 additional stories matching:
Stanford University Medical Center
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!